查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1403381

到 2030 年儿童神经设备市场预测：按产品类型、病理、年龄组、服务/治疗、神经亚专门食品、最终用户和地区进行的全球分析

Pediatric Neurology Devices Market Forecasts to 2030 - Global Analysis By Product Type, Condition, Age Group, Service and Treatment, Neurological Subspecialties, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球儿童神经设备市场规模为 33 亿美元，预计在预测期内将以 9.8% 的复合年增长率成长，到 2030 年达到 64 亿美元。

专门用于诊断、监测和治疗儿童神经系统疾病的医疗设备称为儿童神经设备。这些设备可治疗癫痫、脑性麻痹和发育迟缓等疾病，包括脑电图 (EEG)、儿童用MRI 和復健 CT 扫描仪等各种设备。

根据偏头痛研究基金会的报告，一半的偏头痛患者在 12 岁之前首次发作，偏头痛可能发生在年仅 18 个月大的儿童身上。

对政府计划和计划的需求不断增长

政府倡议透过提供资金、鼓励团队合作和支持先进诊断和治疗设备的开发来培养儿童神经病学领域的创造力，最终改善患者的治疗结果。此外，此类倡议提高了人们对儿童神经系统疾病和专业治疗重要性的认识。因此，只要各国政府继续高度重视儿童医疗保健和研究，儿童神经设备的开发和创新就会持续下去，从而推动该市场的成长。

高成本

专门的儿童神经设备的研究、开发和製造通常需要广泛的研究并且成本高。由于高成本，设备价格可能急剧上升，许多患者和医疗保健提供者无法负担。医疗保健系统的财务负担可能会限制投资于儿童神经病学治疗的最新技术和进步的能力。此外，患者、医疗保健提供者和医疗保健系统的潜在经济负担也是儿童神经科设备行业高定价的主要缺点之一。

技术进步

医疗技术的不断创新正在导致更有效、侵入性更小的设备的开发，用于诊断、监测和治疗儿童神经系统疾病。这些进步包括先进的神经影像技术、神经刺激设备和提高手术精确度和安全性的手术器械。此外，这些创新为医疗保健专业人员提供了日益复杂的工具，以改善患者的治疗效果，减少与治疗相关的不适，并提高儿童患者的生活质量，有助于扩大该市场。

缺乏意识

由于缺乏了解，儿童神经病学设备的采用和使用有限是一个重大缺陷。患者、医疗保健专业人员和医疗专业人员可能不了解所有可用技术或其潜在好处。此外，这可能会导致忽视或延迟使用儿童神经科设备，最终影响患者护理。缺乏意识会减慢该领域的创新和研究步伐，这可能是缩小市场规模的一个因素。

COVID-19 的影响

COVID-19大流行对儿童神经设备市场产生了负面影响，这主要是由于医疗保健系统的中断和经济的不确定性。封锁和限制减少了选择性手术和非紧急咨询的预约，从而影响了儿童神经系统疾病的诊断和治疗。新设备和技术的引进也受到医疗保健系统的财务负担和病患就诊次数减少的影响。

预计神经外科设备产业在预测期内将是最大的。

由于专门用于治疗儿童神经系统问题的手术器械和设备，神经外科设备部分预计将占据最大占有率。其中包括各种仪器，包括儿童用大小的神经科学用内视镜、颅骨固定装置、微创神经外科器械以及针对水脑症和先天性异常等疾病的患者专用植入。此外，它们的设计考虑了儿童患者的特殊解剖和发育需求，使神经外科医生能够提供精确可靠的治疗，并推动该领域的发展。

预计癫痫领域在预测期内复合年增长率最高

由于儿童癫痫盛行率不断上升以及创新设备的开发，预计癫痫领域在预测期内将出现最高的复合年增长率。其中包括监测大脑活动的脑电图、抗癫痫药物、迷走神经刺激设备神经刺激设备和癫痫警报。此外，对用于诊断、监测和治疗儿童患者癫痫发作的设备的重视对于儿童癫痫的治疗至关重要，从而推动了这一领域的扩展。

占有率最大的地区

在估计期间，北美占据最大的市场占有率。随着远端医疗的普及，儿童神经病学服务变得更加广泛。神经影像学和脑电图领域的新发展包括较小的、适合儿童的设备，使儿童测试更加准确和舒适。美国、加拿大和墨西哥等国家正在透过神经刺激技术和资料分析的进步来改善癫痫等疾病的治疗选择，从而改善资料解释，从而推动该地区的成长。

复合年增长率最高的地区：

由于欧洲药品管理局 (EMA) 和国家卫生当局等监管机构对这些设备实施严格的安全性和有效性标准，预计欧洲在预测期内将呈现最高的复合年增长率。美敦力 (Medtronic)、雅培 (Abbott) 实验室、西门子医疗 (Siemens Healthineers) 和波士顿科学公司 (Boston Scientific Corporation) 等主要公司正在为先进儿童用专用诊断工具、治疗设备和监测解决方案的开发和采用做出贡献。此外，在许多欧洲国家，这些设备的成本通常由健康保险或公共医疗保健系统承担，支持在该地区的扩张。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第三章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球儿童神经设备市场：依产品类型

  • 神经外科设备
  • 脑脊髓液管理装置
  • 神经刺激装置
  • 神经介入装置
  • 其他产品类型

第六章全球儿童神经设备市场：依病理状况

  • 发作
  • 中风
  • 水脑症
  • 肿瘤学
  • 其他条件

第七章全球儿童神经设备市场：依年龄组

  • 0-5岁
  • 5-10年
  • 10-15岁

第八章全球儿童神经设备市场：按服务和治疗分类

  • 巴氯芬鞘内注射治疗
  • 迷走神经刺激
  • 脑电图测试
  • 神经学评估
  • 其他服务和治疗

第九章全球儿童神经科设备市场：依神经科专业分类

  • 神经肌肉的
  • 神经免疫学
  • 神经肿瘤学
  • 新生儿神经病学

第10章全球儿童神经设备市场：依最终用户分类

  • 门诊手术中心
  • 医院
  • 其他最终用户

第十一章全球儿童神经设备市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第十二章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十三章 公司简介

  • Medtronic
  • Elana, Inc.
  • Stryker Corporation
  • Inova Healthcare System
  • Boston Scientific Corporation
  • The Nemours Foundation
  • Integra LifeSciences Corporation
  • B.Braun Melsungen AG
  • Abbott Laboratories
  • St. Jude Medical, LLC
  • Zimmer Biomet Holding Inc.
  • LivaNova PLC
  • Natus Medical Incorporated
  • Karl Storz SE & Co. KG
Product Code: SMRC24606

According to Stratistics MRC, the Global Pediatric Neurology Devices Market is accounted for $3.3 billion in 2023 and is expected to reach $6.4 billion by 2030 growing at a CAGR of 9.8% during the forecast period. Medical equipment made especially for the diagnosis, observation, and treatment of neurological diseases in children is known as pediatric neurology equipment. These devices treat disorders including epilepsy, cerebral palsy, and developmental delays, which include a variety of instruments such as electroencephalography (EEG) machines, pediatric MRIs, and CT scanners for rehabilitation.

According to the Migraine Research Foundation report, it has been observed that half of all migraine sufferers have their first attack before the age of 12 and migraine has even been reported to in 18 months old children.

Market Dynamics:

Driver:

Rising demand in government programs and projects

The government initiatives provide funds, encourage teamwork, and foster creativity in the field of pediatric neurology by supporting the development of advanced diagnostic and treatment devices, ultimately improving patient outcomes. Additionally, such initiatives raise awareness about pediatric neurological disorders and the importance of specialized care. Therefore, pediatric neurology devices will continue to develop and innovate as long as governments continue to place a high priority on pediatric healthcare and research, which are driving this market's growth.

Restraint:

High cost

The development and production of specialized pediatric neurology devices often involve extensive research, leading to substantial costs. These high costs can result in inflated prices for devices, making them unaffordable for many patients and healthcare providers. The financial strain on healthcare systems can limit their ability to invest in the latest technologies and advancements in pediatric neurology treatment. Additionally, the possible financial strain on patients, healthcare providers, and healthcare systems is one major drawback of the high pricing in the pediatric neurology device industry.

Opportunity:

Technological advancements

The ongoing innovation in medical technology leads to the development of more effective and minimally invasive devices for diagnosing, monitoring, and treating pediatric neurological disorders. This progress includes advanced neuroimaging techniques, neurostimulation devices, and surgical tools that enhance the precision and safety procedures. Furthermore, these innovations improve patient outcomes, reduce treatment-related discomfort, and contribute to a better quality of life for pediatric patients by providing healthcare professionals with increasingly sophisticated tools, which is boosting this market expansion.

Threat:

Lack of awareness

The restricted adoption and utilization of pediatric neurology equipment is a significant drawback resulting from a lack of understanding. Patients, caregivers, and healthcare professionals may not be aware of all the technologies that are available or all of their potential advantages. In addition, this may result in pediatric neurology equipment being neglected or adopted more slowly, which would ultimately affect patient treatment. The lack of awareness may contribute to a slower pace of innovation and research in the field, thereby impeding this market size.

COVID-19 Impact

The COVID-19 pandemic has had negative impacts on the pediatric neurology device market, primarily due to disruptions in healthcare systems and economic uncertainties. Lockdowns and restrictions led to a reduction in elective procedures and non-urgent medical appointments, affecting the diagnosis and treatment of pediatric neurological conditions. The adoption of new gadgets and technology was also impacted by the financial strains placed on healthcare systems and the decline in patient visits.

The neurosurgery devices segment is expected to be the largest during the forecast period

The neurosurgery devices segment is estimated to hold the largest share due to surgical instruments and equipment specifically made for treating neurological problems in children. This covers a broad spectrum of devices, including pediatric-sized neuroendoscopes, cranial fixation devices, minimally invasive neurosurgical instruments, and patient-specific implants for ailments such as hydrocephalus and congenital abnormalities. Additionally, these enable neurosurgeons to carry out accurate and secure treatments as they are designed with the special anatomical and developmental needs of pediatric patients, which are driving this segment's growth.

The seizures segment is expected to have the highest CAGR during the forecast period

The seizures segment is anticipated to have highest CAGR during the forecast period due to the increasing prevalence of pediatric epilepsy and the ongoing development of innovative devices. This includes electroencephalography (EEG) machines for monitoring brain activity, anti-seizure medications, neurostimulation devices like vagus nerve stimulators, and seizure alarms. Furthermore, it focuses on devices designed to diagnose, monitor, and treat seizures in pediatric patients and are crucial in the management of pediatric epilepsy which are thereby boosting this segment's expansion.

Region with largest share:

North America commanded the largest market share during the extrapolated period. Pediatric neurology services are now more widely accessible due to the rise in popularity of telemedicine alternatives. New developments in the field of neuroimaging and EEG include smaller, more kid-friendly equipment that makes examinations of children more accurate and comfortable. Countries such as the United States, Canada, and Mexico have improved therapy options for diseases like epilepsy due to developments in neurostimulation techniques and data analytics to improve data interpretation, which are propelling this region's growth.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period, owing to the regulatory organizations like the European Medicines Agency (EMA) and national health agencies which impose strict safety and efficacy standards for these devices. Major Key players such as Medtronic plc, Abbott Laboratories, Siemens Healthineers and Boston Scientific Corporation contribute to development and adoption of sophisticated diagnostic tools, therapeutic devices, and monitoring solutions tailored specifically for children. Furthermore, the cost of these devices is frequently covered by health insurance and public healthcare systems in many European nations which are driving this region's expansion.

Key players in the market:

Some of the key players in the Pediatric Neurology Devices Market include Medtronic, Elana, Inc., Stryker Corporation, Inova Healthcare System, Boston Scientific Corporation, The Nemours Foundation, Integra LifeSciences Corporation, B.Braun Melsungen AG, Abbott Laboratories, St. Jude Medical, LLC, Zimmer Biomet Holding Inc., LivaNova PLC, Natus Medical Incorporated and Karl Storz SE & Co. KG.

Key Developments:

In October 2023, Boston Scientific Corporation announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication of the WaveWriter Alpha™ Spinal Cord Stimulator (SCS) Systems for the treatment of painful diabetic peripheral neuropathy (DPN), a complication of diabetes that can affect the lower extremities of the body.

In September 2023, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company that has developed and commercialized the Intracept® Intraosseous Nerve Ablation System to treat vertebrogenic pain, a form of chronic low back pain.

In June 2023, Amcor the American Diabetes Association® and Abbott announced collaboration aimed at better understanding how diabetes technology like continuous glucose monitoring (CGM) systems can help people living with diabetes make informed decisions about their food and activity.

In March 2023, Somatus, the nation's leading and largest value-based kidney Care Company, and Inova Health System announce the new Nurse Navigator Program launch, an innovative addition to the already successful partnership.

Product Types Covered:

  • Neurosurgery Devices
  • Cerebrospinal Fluid Management Devices
  • Neurostimulation Devices
  • Interventional Neurology Devices
  • Other Product Types

Conditions Covered:

  • Seizures
  • Stroke
  • Hydrocephalus
  • Oncology
  • Other Conditions

Age Group Covered:

  • 0-5 Years
  • 5-10 Years
  • 10-15 Years

Service and Treatments Covered:

  • Intrathecal baclofen therapy
  • Vagal nerve stimulation
  • Electroencephalogram
  • Neurological Evaluations
  • Other Service and Treatments

Neurological Subspecialties Covered:

  • Neuromuscular
  • Neuroimmunology
  • Neuro-oncology
  • Neonatal Neurology

End Users Covered:

  • Ambulatory surgery centers
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pediatric Neurology Devices Market, By Product Type

  • 5.1 Introduction
  • 5.2 Neurosurgery Devices
  • 5.3 Cerebrospinal Fluid Management Devices
  • 5.4 Neurostimulation Devices
  • 5.5 Interventional Neurology Devices
  • 5.6 Other Product Types

6 Global Pediatric Neurology Devices Market, By Condition

  • 6.1 Introduction
  • 6.2 Seizures
  • 6.3 Stroke
  • 6.4 Hydrocephalus
  • 6.5 Oncology
  • 6.6 Other Conditions

7 Global Pediatric Neurology Devices Market, By Age Group

  • 7.1 Introduction
  • 7.2 0-5 Years
  • 7.3 5-10 Years
  • 7.4 10-15 Years

8 Global Pediatric Neurology Devices Market, By Service and Treatment

  • 8.1 Introduction
  • 8.2 Intrathecal baclofen therapy
  • 8.3 Vagal nerve stimulation
  • 8.4 Electroencephalogram
  • 8.5 Neurological Evaluations
  • 8.6 Other Service and Treatments

9 Global Pediatric Neurology Devices Market, By Neurological Subspecialties

  • 9.1 Introduction
  • 9.2 Neuromuscular
  • 9.3 Neuroimmunology
  • 9.4 Neuro-oncology
  • 9.5 Neonatal Neurology

10 Global Pediatric Neurology Devices Market, By End User

  • 10.1 Introduction
  • 10.2 Ambulatory surgery centers
  • 10.3 Hospitals
  • 10.4 Other End Users

11 Global Pediatric Neurology Devices Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Medtronic
  • 13.2 Elana, Inc.
  • 13.3 Stryker Corporation
  • 13.4 Inova Healthcare System
  • 13.5 Boston Scientific Corporation
  • 13.6 The Nemours Foundation
  • 13.7 Integra LifeSciences Corporation
  • 13.8 B.Braun Melsungen AG
  • 13.9 Abbott Laboratories
  • 13.10 St. Jude Medical, LLC
  • 13.11 Zimmer Biomet Holding Inc.
  • 13.12 LivaNova PLC
  • 13.13 Natus Medical Incorporated
  • 13.14 Karl Storz SE & Co. KG

List of Tables

  • Table 1 Global Pediatric Neurology Devices Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Pediatric Neurology Devices Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Pediatric Neurology Devices Market Outlook, By Neurosurgery Devices (2021-2030) ($MN)
  • Table 4 Global Pediatric Neurology Devices Market Outlook, By Cerebrospinal Fluid Management Devices (2021-2030) ($MN)
  • Table 5 Global Pediatric Neurology Devices Market Outlook, By Neurostimulation Devices (2021-2030) ($MN)
  • Table 6 Global Pediatric Neurology Devices Market Outlook, By Interventional Neurology Devices (2021-2030) ($MN)
  • Table 7 Global Pediatric Neurology Devices Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 8 Global Pediatric Neurology Devices Market Outlook, By Condition (2021-2030) ($MN)
  • Table 9 Global Pediatric Neurology Devices Market Outlook, By Seizures (2021-2030) ($MN)
  • Table 10 Global Pediatric Neurology Devices Market Outlook, By Stroke (2021-2030) ($MN)
  • Table 11 Global Pediatric Neurology Devices Market Outlook, By Hydrocephalus (2021-2030) ($MN)
  • Table 12 Global Pediatric Neurology Devices Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 13 Global Pediatric Neurology Devices Market Outlook, By Other Conditions (2021-2030) ($MN)
  • Table 14 Global Pediatric Neurology Devices Market Outlook, By Age Group (2021-2030) ($MN)
  • Table 15 Global Pediatric Neurology Devices Market Outlook, By 0-5 Years (2021-2030) ($MN)
  • Table 16 Global Pediatric Neurology Devices Market Outlook, By 5-10 Years (2021-2030) ($MN)
  • Table 17 Global Pediatric Neurology Devices Market Outlook, By 10-15 Years (2021-2030) ($MN)
  • Table 18 Global Pediatric Neurology Devices Market Outlook, By Service and Treatment (2021-2030) ($MN)
  • Table 19 Global Pediatric Neurology Devices Market Outlook, By Intrathecal baclofen therapy (2021-2030) ($MN)
  • Table 20 Global Pediatric Neurology Devices Market Outlook, By Vagal nerve stimulation (2021-2030) ($MN)
  • Table 21 Global Pediatric Neurology Devices Market Outlook, By Electroencephalogram (2021-2030) ($MN)
  • Table 22 Global Pediatric Neurology Devices Market Outlook, By Neurological Evaluations (2021-2030) ($MN)
  • Table 23 Global Pediatric Neurology Devices Market Outlook, By Other Service and Treatments (2021-2030) ($MN)
  • Table 24 Global Pediatric Neurology Devices Market Outlook, By Neurological Subspecialties (2021-2030) ($MN)
  • Table 25 Global Pediatric Neurology Devices Market Outlook, By Neuromuscular (2021-2030) ($MN)
  • Table 26 Global Pediatric Neurology Devices Market Outlook, By Neuroimmunology (2021-2030) ($MN)
  • Table 27 Global Pediatric Neurology Devices Market Outlook, By Neuro-oncology (2021-2030) ($MN)
  • Table 28 Global Pediatric Neurology Devices Market Outlook, By Neonatal Neurology (2021-2030) ($MN)
  • Table 29 Global Pediatric Neurology Devices Market Outlook, By End User (2021-2030) ($MN)
  • Table 30 Global Pediatric Neurology Devices Market Outlook, By Ambulatory surgery centers (2021-2030) ($MN)
  • Table 31 Global Pediatric Neurology Devices Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 32 Global Pediatric Neurology Devices Market Outlook, By Other End Users (2021-2030) ($MN)

Table Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.